Expression of SET protein in the ovaries of patients with polycystic ovary syndrome

International Journal of Endocrinology

Volumn 2013, Issue , 2013, Pages

  Boqun, Xu ^a,b   Xiaonan, Dai ^a   Yugui, Cui ^a   Lingling, Gao ^a   Xue, Dai ^b   Gao, Chao ^a   Feiyang, Diao ^a   Jiayin, Liu ^a   Gao, Li ^a   Li, Mei ^a   Zhang, Yuan ^a   Ma, Xiang ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

REGULATOR PROTEIN; SET PROTEIN; UNCLASSIFIED DRUG;

ADULT; ANDROGEN SYNTHESIS; ARTICLE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERANDROGENISM; IMMUNOHISTOCHEMISTRY; MOLECULAR PATHOLOGY; OOCYTE; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; THECA CELL; WESTERN BLOTTING;

EID: 84879322193     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2013/367956     Document Type: Article

References (24)

1. Fauser B. C. J. M., Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility and Sterility 2004 81 1 19 25 2-s2.0-0346725827 10.1016/j.fertnstert.2003.10.004
2. Ehrmann D. A., Polycystic ovary syndrome. The New England Journal of Medicine 2005 352 12 1223 1277 2-s2.0-15444366255 10.1056/NEJMra041536
3. Nelson V. L., Legro R. S., Strauss J. F. 3rd, McAllister J. M., Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries. Molecular Endocrinology 1999 13 6 946 957 2-s2.0-0033304623
4. Nelson V. L., Qin K. N., Rosenfield R. L., Wood J. R., Penning T. M., Legro R. S., Strauss J. F., McAllister J. M., The biochemical basis for increased Testosterone production in theca cells propagated from patients with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2001 86 12 5925 5933 2-s2.0-0035217099 10.1210/jc.86.12.5925
5. Nakajin S., Hall P. F., Microsomal cytochrome P-450 from neonatal pig testis. Purification and properties of A C21 steroid side-chain cleavage system (17 alpha-hydroxylase-C17,20 lyase). The Journal of Biological Chemistry 1981 256 8 3871 3876 2-s2.0-0019887951
6. Wickenheisser J. K., Nelson-DeGrave V. L., McAllister J. M., Dysregulation of cytochrome P450 17 α -hydroxylase messenger ribonucleic acid stability in theca cells isolated from women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2005 90 3 1720 1727 2-s2.0-15944407338 10.1210/jc.2004-1860
7. Wood J. R., Nelson V. L., Ho C., Jansen E., Wang C. Y., Urbanek M., McAllister J. M., Mosselman S., Strauss J. F., The molecular phenotype of polycystic ovary syndrome (PCOS) theca cells and new candidate PCOS genes defined by microarray analysis. The Journal of Biological Chemistry 2003 278 29 26380 26390 2-s2.0-0038374441 10.1074/jbc.M300688200
8. Diao F. Y., Xu M., Hu Y., Li J., Xu Z., Lin M., Wang L., Zhou Y., Zhou Z., Liu J., Sha J., The molecular characteristics of polycystic ovary syndrome (PCOS) ovary defined by human ovary cDNA microarray. Journal of Molecular Endocrinology 2004 33 1 59 72 2-s2.0-4444260304 10.1677/jme.0.0330059
9. Von Lindern M., Van Baal S., Wiegant J., Raap A., Hagemeijer A., Grosveld G., can, a putative oncogene associated with myeloid leukemogenesis, may be activated by fusion of its 3' half to different genes: characterization of the set gene. Molecular and Cellular Biology 1992 12 8 3346 3355 2-s2.0-0026693436
10. Nagata K., Kawase H., Handa H., Yano K., Yamasaki M., Ishimi Y., Okuda A., Kikuchi A., Matsumoto K., Replication factor encoded by a putative oncogene, set, associated with myeloid leukemogenesis. Proceedings of the National Academy of Sciences of the United States of America 1995 92 10 4279 4283 2-s2.0-0029009403
11. Nagata K., Saito S., Okuwaki M., Kawase H., Furuya A., Kusano A., Hanai N., Okuda A., Kikuchi A., Cellular localization and expression of template-activating factor I in different cell types. Experimental Cell Research 1998 240 2 274 281 2-s2.0-0031827168 10.1006/excr.1997.3930
12. Karetsou Z., Martic G., Sflomos G., Papamarcaki T., The histone chaperone SET/TAF-I β interacts functionally with the CREB-binding protein. Biochemical and Biophysical Research Communications 2005 335 2 322 327 2-s2.0-23744433864 10.1016/j.bbrc.2005.06.210
13. Li M., Makkinje A., Damuni Z., The myeloid leukemia-associated protein SET is a potent inhibitor of protein phosphatase 2A. The Journal of Biological Chemistry 1996 271 19 11059 11062 2-s2.0-0029889342 10.1074/jbc.271.19.11059
14. Seo S. B., McNamara P., Heo S., Turner A., Lane W. S., Chakravarti D., Regulation of histone acetylation and transcription by INHAT, a human cellular complex containing the set oncoprotein. Cell 2001 104 1 119 130 2-s2.0-0035846894 10.1016/S0092-8674(01)00196-9
15. Zhang P., Compagnone N. A., Fiore C., Vigne J. L., Culp P., Musci T. J., Mellon S. H., Developmental gonadal expression of the transcription factor set and its target gene, P450c17 (17 α -hydroxylase/c17,20 lyase). DNA and Cell Biology 2001 20 10 613 624 2-s2.0-0035694982 10.1089/104454901753340604
16. Compagnone N. A., Zhang P., Vigne J. L., Mellon S. H., Novel role for the nuclear phosphoprotein SET in transcriptional activation of P450c17 and initiation of neurosteroidogenesis. Molecular Endocrinology 2000 14 6 875 888 2-s2.0-0034465596 10.1210/me.14.6.875
17. Wagner S., Weber S., Kleinschmidt M. A., Nagata K., Bauer U. M., SET-mediated promoter hypoacetylation is a prerequisite for coactivation of the estrogen-responsive pS2 gene by PRMT1. The Journal of Biological Chemistry 2006 281 37 27242 27250 2-s2.0-33748751950 10.1074/jbc.M605172200
18. Zhang P., Mellon S. H., Multiple orphan nuclear receptors converge to regulate rat P450c17 gene transcription: Novel mechanisms for orphan nuclear receptor action. Molecular Endocrinology 1997 11 7 891 904 2-s2.0-0030961743 10.1210/me.11.7.891
19. Arnaud L., Chen S., Liu F., Li B., Khatoon S., Grundke-Iqbal I., Iqbal K., Mechanism of inhibition of PP2A activity and abnormal hyperphosphorylation of tau by I2(PP2A)/SET. FEBS Letters 2011 585 17 2653 2659
20. Pandey A. V., Mellon S. H., Miller W. L., Protein phosphatase 2A and phosphoprotein SET regulate androgen production by P450c17. The Journal of Biological Chemistry 2003 278 5 2837 2844 2-s2.0-0037474198 10.1074/jbc. M209527200
21. Chang H. Y., Jennings P. C., Stewart J., Verrills N. M., Jones K. T., Essential role of protein phosphatase 2A in metaphase II arrest and activation of mouse eggs shown by okadaic acid, dominant negative protein phosphatase 2A, and FTY720. The Journal of Biological Chemistry 2011 286 16 14705 14712 2-s2.0-79954578095 10.1074/jbc.M110.193227
22. Azziz R., Carmina E., Dewailly D., Diamanti-Kandarakis E., Escobar-Morreale H. F., Futterweit W., Janssen O. E., Legro R. S., Norman R. J., Taylor A. E., Witchel S. F., Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline. Journal of Clinical Endocrinology and Metabolism 2006 91 11 4237 4245 2-s2.0-33751526500 10.1210/jc.2006-0178
23. Wickenheisser J. K., Nelson-DeGrave V. L., McAllister J. M., Human ovarian theca cells in culture. Trends in endocrinology and metabolism: TEM 2006 17 2 65 71 2-s2.0-33646446629 10.1016/j.tem.2006.01.003
24. Wickenheisser J. K., Quinn P. G., Nelson V. L., Legro R. S., Strauss J. F., Mcallister J. M., Differential activity of the cytochrome P450 17 α -hydroxylase and steroidogenic acute regulatory protein gene promoters in normal and polycystic ovary syndrome theca cells. Journal of Clinical Endocrinology and Metabolism 2000 85 6 2304 2311 2-s2.0-0034457443 10.1210/jc.85.6.2304